American Century Companies Inc Regenxbio Inc. Transaction History

American Century Companies Inc

$157 Billion
Q1 2025

A detailed history of American Century Companies Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, American Century Companies Inc holds 101,579 shares of RGNX stock, worth $994,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101,579

Previous 95,026 6.9%

Holding current value

$994,458

Previous $734,000 1.09%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$5.92 - $8.7 $38,793 - $57,011	6,553 Added 6.9%	101,579 $726,000
Q4 2024 Feb 11, 2025	BUY	$7.23 - $11.56 $55,367 - $88,526	7,658 Added 8.77%	95,026 $734,000
Q3 2024 Nov 12, 2024	BUY	$10.49 - $14.39 $131,083 - $179,817	12,496 Added 16.69%	87,368 $916,000
Q2 2024 Aug 07, 2024	BUY	$11.51 - $21.53 $123,928 - $231,813	10,767 Added 16.8%	74,872 $876,000
Q1 2024 May 14, 2024	BUY	$12.17 - $24.61 $183,268 - $370,601	15,059 Added 30.7%	64,105 $1.35 Million
Q4 2023 Feb 13, 2024	BUY	$12.89 - $20.82 $632,202 - $1.02 Million	49,046 New	49,046 $880,000
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $785,948 - $954,502	-47,749 Reduced 17.99%	217,698 $3.58 Million
Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $1.99 Million - $2.5 Million	-115,304 Reduced 30.28%	265,447 $5.31 Million
Q1 2023 May 11, 2023	SELL	$18.08 - $24.55 $57,512 - $78,093	-3,181 Reduced 0.83%	380,751 $7.2 Million
Q4 2022 Feb 13, 2023	BUY	$20.4 - $24.73 $1.41 Million - $1.71 Million	69,214 Added 21.99%	383,932 $8.71 Million
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $1.67 Million - $2.63 Million	75,053 Added 31.32%	314,718 $8.32 Million
Q2 2022 Aug 12, 2022	BUY	$19.35 - $35.04 $3.71 Million - $6.72 Million	191,668 Added 399.33%	239,665 $5.92 Million
Q1 2022 May 11, 2022	BUY	$24.62 - $34.31 $1.18 Million - $1.65 Million	47,997 New	47,997 $1.59 Million
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $2.25 Million - $5.68 Million	-104,713 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$34.54 - $44.87 $1.47 Million - $1.9 Million	42,438 Added 68.15%	104,713 $4.29 Million
Q3 2019 Nov 13, 2019	BUY	$31.84 - $50.88 $115,451 - $184,490	3,626 Added 6.18%	62,275 $2.22 Million
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $1.32 Million - $1.87 Million	-31,491 Reduced 34.94%	58,649 $3.01 Million
Q1 2019 May 14, 2019	BUY	$40.82 - $62.45 $1.69 Million - $2.59 Million	41,483 Added 85.26%	90,140 $0
Q4 2018 Feb 13, 2019	BUY	$39.11 - $75.15 $1.28 Million - $2.46 Million	32,734 Added 205.58%	48,657 $2.04 Million
Q3 2018 Nov 02, 2018	BUY	$65.0 - $82.15 $27,235 - $34,420	419 Added 2.7%	15,923 $1.2 Million
Q2 2018 Aug 08, 2018	BUY	$27.2 - $74.35 $421,708 - $1.15 Million	15,504 New	15,504 $1.11 Million

Others Institutions Holding RGNX

# of Institutions

181

Shares Held

45.3M

Call Options Held

64.9K

Put Options Held

103K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $423M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Regenxbio Inc. Transaction History